Your browser doesn't support javascript.
Endocrine Conditions and COVID-19.
Shekhar, Skand; Wurth, Rachel; Kamilaris, Crystal D C; Eisenhofer, Graeme; Barrera, Francisco J; Hajdenberg, Michelle; Tonleu, Joselyne; Hall, Janet E; Schiffrin, Ernesto L; Porter, Forbes; Stratakis, Constantine A; Hannah-Shmouni, Fady.
  • Shekhar S; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Wurth R; Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA.
  • Kamilaris CDC; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Eisenhofer G; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Barrera FJ; Institute of Clinical Chemistry and Laboratory Medicine, and Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hajdenberg M; Endocrinology Division, Internal Medicine Department, University Hospital "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Tonleu J; Plataforma INVEST-KER Unit Mayo Clinic, School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Hall JE; College of Arts and Sciences at Washington University in St. Louis, Saint Louis, Missouri, USA.
  • Schiffrin EL; Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA.
  • Porter F; Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA.
  • Stratakis CA; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Hannah-Shmouni F; Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Horm Metab Res ; 52(7): 471-484, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-591840
ABSTRACT
COVID-19 was declared a global pandemic by the WHO and has affected millions of patients around the world. COVID-19 disproportionately affects persons with endocrine conditions, thus putting them at an increased risk for severe disease. We discuss the mechanisms that place persons with endocrine conditions at an additional risk for severe COVID-19 and review the evidence. We also suggest precautions and management of endocrine conditions in the setting of global curfews being imposed and offer practical tips for uninterrupted endocrine care.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Endocrine System Diseases Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Horm Metab Res Year: 2020 Document Type: Article Affiliation country: A-1172-1352

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Endocrine System Diseases Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Horm Metab Res Year: 2020 Document Type: Article Affiliation country: A-1172-1352